期刊文献+

高负荷剂量氯吡格雷在急性冠状动脉综合征中的应用 被引量:1

The Application of High-loading-dose of Clopidogrel in Acute Coronary Syndrome
下载PDF
导出
摘要 作为一种新型的抗血小板制剂,氯吡格雷近年来广泛应用于临床,尤其是急性冠状动脉综合征患者。研究证实,氯吡格雷对急性冠状动脉综合征患者有良好的疗效。高负荷剂量氯吡格雷具有何效果。现就应用高负荷剂量氯吡格雷治疗急性冠状动脉综合征的有效性和安全性进行综述。 As a new kind of antiplalete medicine,clopidogrel has been widely used in clinical experiences,especially in patients wtih Acute Coronary Syndrome.Many studies confirmed its good effect in Acute Coronary Syndrome.The application of high-loading-dose of Clopidogrel is attracting more and more attention.In this article,we reviewed the efficacy and security of high-loading-dose of Clopidogrel in Acute Coronary Syndrome.
作者 叶少强 吴铿
出处 《医学综述》 2008年第6期914-916,共3页 Medical Recapitulate
关键词 急性冠状动脉综合征 高负荷剂量 氯吡格雷 High-loading-dose Clopidogrel Acute coronary syndrome
  • 相关文献

参考文献18

  • 1Mehta SR, Yusuf S, Peter RJ,et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention : the PCI-CURE stydy [ J ]. Lancet,2001,358(4 ) :527-533.
  • 2Steinhubl SR, Berger PB, Mann JT 3rd,et al. For the CREDO investigatiors,early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial [ J ]. JAMA,2002,288 ( 19 ) :2411-2420.
  • 3Angiolillo DJ, Fernandez-Ortiz A, Bernardo E ,et al. Is a 300mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study [ J ]. Invasive Cardio1,2004,16 ( 6 ) : 325 -329.
  • 4Pache J, Kastrati A, Mehilli J, et al. Clopidogrel therapy in patients undergoing coronary stenting: value of a high-loading-dose regimen [ J]. Cathet Cardiovase Interv,2002,55 (4) :436-441.
  • 5Montalescot G, Sideris G, Meuleman C,et al. A Randomized comparison of high clopidogrel loading dose in patients with NON-ST-Segment elevation acute coronary syndormes:The ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial [ J ]. Am Coll Cardiol, 2006,48 (5) :931-938.
  • 6CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin patients at risk of ischaemic events (CAPRIE) [ J ]. Lancet, 1996,348 (9038). : 1329-1339.
  • 7CURE stydy Investigators. The clopidogrel in unstable angia to prevent recurrent events ( CURE ) trial programme; rationale, design, and baseline characteristics including a meta-analysis of thienopyridines in vascular disease [ J ]. Eur Heart J, 2000,21 ( 24 ) : 2033- 2041.
  • 8Sabatine MS, Cannon CP, Gibson CM, et al. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study [ J ]. JAMA, 2005 14,294 ( 10 ) : 1224- 1232.
  • 9Chen ZM ,Jiang LX,Chen YP,et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction:random- ised placebo-controlled trial [ J ]. Lancet, 2005,366 ( 9497 ) : 1607- 1621.
  • 10Sullmov VA, Malova EV, Svrkin AL, et al. Effectiveness and safety of clopidogrel bisulfate in complex therapy of patients with acute coronary syndrome with ST segment elevation [ J ]. Kardiologiia, 2006,46(7) :26-32.

同被引文献10

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部